Ginsenoside Rh1

CAT:

804-HY-N0604-01

Size:

5 mg

Price:

Ask

For price, please contact [email protected]

CAS Number: 63223-86-9
UNSPSC Description: Ginsenoside Rh1 (Prosapogenin A2) inhibits the expression of PPAR-γ, TNF-α, IL-6, and IL-1β.
Target Antigen: Endogenous Metabolite; Interleukin Related; PPAR; TNF Receptor
Type: Natural Products
Related Pathways: Apoptosis;Cell Cycle/DNA Damage;Immunology/Inflammation;Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor
Applications: COVID-19-anti-virus
Field of Research: Inflammation/Immunology
Assay Protocol: https://www.medchemexpress.com/Ginsenoside-Rh1.html
Purity: 98.0
Solubility: DMSO : 100 mg/mL (ultrasonic)
Smiles: C[C@@]([C@@]12C)(C[C@H](O[C@]([C@@H]([C@@H](O)[C@@H]3O)O)([H])O[C@@H]3CO)[C@@]4([H])C5(C)C)[C@@](C[C@@H](O)[C@]1([H])[C@]([C@@](C)(O)CC/C=C(C)/C)([H])CC2)([H])[C@]4(CC[C@@H]5O)C
Molecular Weight: 638.87
References & Citations: [1]Gu W, et al. Ginsenoside Rh1 ameliorates high fat diet-induced obesity in mice by inhibiting adipocyte differentiation. Biol Pharm Bull. 2013;36(1):102-7.
Shipping Conditions: Room Temperature
Storage Conditions: -20°C, 3 years; 4°C, 2 years (Powder)
Clinical Information: No Development Reported